HONOLULU – The Hawai‘i Department of Health announces scheduling opportunities for the COVID-19 vaccine manufactured by Novavax.Novavax is a two-dose primary series vaccine for individuals 18 and older.
The Centers for Disease Control and Prevention recommends administering the second dose three to eight weeks after the first.Novavax is a protein subunit vaccine.
It includes harmless proteins of the COVID-19 virus that trigger an immune response.Protein subunit vaccines, which include vaccines for hepatitis B, whooping cough, shingles, and other diseases, have been used in the United States for more than 30 years.“Novavax gives us another way to protect ourselves from COVID-19.
Its arrival is great news for people who are allergic to an ingredient in the mRNA vaccines manufactured by Pfizer and Moderna or those who, for whatever reason, have been reluctant to be vaccinated,” said State Health Director Dr.